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Abstract
Background: Treatment fidelity tools are frequently used in clinical trials, promoting treatment consistency and 
therefore validity of trial findings. However, treatment fidelity procedures have not been included within international clinical 
trial guidelines such as the Consolidated Standards of Reporting Trials (CONSORT 2010). 
Aim: This study systematically reviews psychological clinical trials that incorporate Treatment Fidelity procedures and 
appraises their implementation using the Implementation of Treatment Integrity Procedures Scale (ITIPS).
Method: Using the PRISMA Checklist as a guide for systematic review, a comprehensive search of the Medline, 
PsychINFO, Ovid, Cochrane Library, Scopus, PUBMED databases for the period 2004 to 2014 resulted in retrieval of 3186 
potential articles. Thirty-two studies meeting inclusion criteria were analysed against the ITIPS.
Results: Sixteen studies were assessed as ‘approaching adequacy’ in implementing Treatment Fidelity procedures as 
measured by the ITIPS scale, 8 studies were assessed as ‘adequate’ whilst a further 8 studies were deemed ‘inadequate’ 
against this assessment. Treatment Fidelity tools generally increased the intensity of the intervention or program within 
which they were used, resulting in improved levels of Treatment Fidelity. 
Conclusion: Current evidence supporting the inclusion of Treatment Fidelity tools is limited since there have been 
relatively few published studies examining the effectiveness of Treatment Fidelity tools. Further research into the efficacy, 
feasibility and measurement of Treatment Fidelity in implementing treatments is recommended, in tandem with additions 
to the CONSORT Guidelines to better support the inclusion of Treatment Fidelity procedures within clinical trials.
Keywords: Treatment fidelity; Integrity; Adherence; Competence;
Scales; Mental health research
Review Contributions to Existing Research
• Assesses	 current	 evidence	 and	 identifies	 areas	 for	 future
research 
• Highlights	 several	 key	 strengths	 of	 Treatment	 Fidelity	 in
improving	quality	assurance	and	implementation	strategies	for
clinical trials
• Finds	 limited	 use	 of	 Treatment	 Fidelity	 procedures	 within
current	clinical	trials
• Provides	 evidence	 to	 support	 the	 inclusion	 of	 Treatment
Fidelity	tools	in	the	CONSORT	Guidelines.
Introduction
Treatment fidelity concepts
The	 last	 decade	 has	 witnessed	 rapid	 development	 in	 Treatment	
Fidelity	research	tailored	to	enhance	therapy	implementation	including	
progress	 in	 terms	 of	 fidelity	 definitions,	 strategies,	 and	 approaches	
to	maintenance.	 Accurate	 assessment	 of	 the	 effectiveness	 of	 therapy	
requires	 knowledge	 of	 the	 degree	 of	 Treatment	 Fidelity	 within	 the	
program	under	evaluation.	Treatment	Fidelity	has	been	an	important	
topic	in	the	psychosocial	research	as	it	thus	has	important	implications	
for	clinical	practices.	It	provides	evidence	as	to	whether	the	treatment	
being	 investigated	was	 implemented	 in	accordance	 to	 recommended	
protocols.	 Without	 this	 evidence	 it	 is	 difficult	 to	 ascertain	 the	
effectiveness	of	any	given	therapy.	Early	conceptualization	of	Treatment	
Fidelity,	also	referred	to	as	 ‘treatment	integrity’	or	 ‘treatment	purity’,	
was	 described	 as	 treatment	 delivered	 as	 intended	 [1].	 Subsequently,	
‘treatment	 differentiation’	 gained	 favour	 amongst	 researchers	 as	 a	
descriptor	of	Treatment	Fidelity;	 this	 referred	 to	whether	or	not	 the	
treatment	implemented	differed	from	its	intended	manner	[2-4].	Later	
again,	‘treatment	receipt’	emerged	as	a	separate	element	of	Treatment	
Fidelity.	 Defined	 as	 whether	 the	 client	 comprehended	 and	 used	 the	
treatment	 skills	 taught	 during	 the	 sessions	 [5].	 As	 the	 field	 evolved,	
‘treatment	enactment’	was	identified	as	a	Treatment	Fidelity	element	
that	evaluated	whether	the	client	applied	skills	 learnt	 in	treatment	to	
their	daily	life	[6,7].	Leichsenring	and	colleagues	[1],	expanded	further	
defining	 Treatment	 Fidelity	 as	 a	 means	 of	 exploring:	 (i)	 whether	 a	
treatment	delivered	is	representative	of	the	theoretical	constructs	and	
mechanisms	presumed	to	underpin	its	purpose,	(ii)	the	extent	to	which	
treatment	effects	are	causally	attributed	to	the	treatment	implemented	
and	(iii)	whether	these	methods	are	generalizable	in	the	clinical	setting.
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Fidelity tools
The	 introduction	 of	 treatment	 manuals	 allowed	 interventions	
under	 empirical	 investigation	 to	 be	 operationalised	 to	 best	 support	
therapy	 delivery	 in	 line	 with	 designed	 treatment	 structures	 [8,9].	
Manualisation	enabled	an	intervention	to	be	monitored	for	Treatment	
Fidelity	levels	according	to	the	research	protocols	[4,7].	In	the	area	of	
psychology	and	therapy	implementations,	a	number	of	researchers	have	
described	manuals	as	a	reliable	and	cost	effective	mechanism	to	support	
Treatment	Fidelity	 to	maximize	 targeted	outcomes	[10-13].	However,	
several	researchers	argue	mutualized	treatments	do	not	ensure	effective	
delivery	of	the	treatment	[14-18].	This	helps	to	explain	the	introduction	
of	 adherence	 and	 competence	 scales	 to	 enhance	 the	 assessment	 and	
measurement	of	Treatment	Fidelity.	
The	value	of	measuring	adherence	and	competence	 to	determine	
the	quality	of	Treatment	Fidelity	 is	a	 fundamental	consideration	[19-
21].	 Adherence	 is	 expressed	 as	 the	 delivery	 of	 a	 key	 component	 or	
technique	 of	 the	 treatment	 [9].	 In	 contrast,	 competence	 measures	
assess	the	skills	or	accuracy	with	which	the	treatment	is	implemented	
[22,23].	Quantitative	and	qualitative	research	methods	are	pivotal	tools	
for	the	investigation	of	these	complex	Treatment	Fidelity	phenomena	
[24-27].	Despite	advances	in	the	field	of	Treatment	Fidelity,	studies	of	
treatment	adherence	and	competence	continue	to	reveal	inconsistencies	
between	treatment	and	outcome	[28].	Perepletchikova	and	Kazdin	[29]	
suggested	 that	 adequate	Treatment	 Fidelity	measures	 are	 essential	 in	
research	 settings	 to	 explain	 such	 inconsistencies.	 Treatment	 Fidelity	
procedures	can	assist	in	exploration	of	associations	between	outcomes	
and	features	of	the	intervention,	or	the	therapist.
 Treatment fidelity in randomised clinical trials
Randomised	 controlled	 trials	 (RCT)	 are	 a	 rigorous	 means	
of	 describing	 and	 determining	 the	 existence	 of	 cause	 and	 effect	
relationships	 between	 treatment	 and	 outcome,	 and	 assessing	 the	
cost-effectiveness	 of	 a	 treatment.	 When	 clinical	 trials	 are	 designed,	
delivered,	analysed	and	 interpreted,	generalisation	and	attribution	of	
findings	are	possible.	However,	published	clinical	trials	can	yield	biased	
results,	 lack	 methodological	 rigour,	 and	 may	 provide	 incomplete	
reporting,	thus	limiting	the	opportunity	for	replication	of	studies	[30].	
In	1998,	these	known	limitations	were	a	catalyst	for	the	development	
of	the	Consolidated	Standards	of	Reporting	Trials	(CONSORT),	which	
were	subsequently	updated	in	2001	and	2010	[31,32].	The	CONSORT	
were	developed	to	help	improve	the	quality	of	clinical	trials	in	terms	of	
accuracy,	clarity,	transparency,	research	design	and	findings	[31,33].	
Members	 of	 the	National	 Institute	 of	Health	 (NIH)	 Behavioural	
Change	 Consortium	 (BCC)	 offered	 a	 comprehensive	 Treatment	
Fidelity	 Framework	 that	 included	 a	 five-part	 theoretical	 model	 for	
Treatment	 Fidelity	 in	 clinical	 trials	 [34].	 The	 model	 suggested	 the	
following	factors	be	considered	when	designing	a	trial;	(i)	study	design;	
(ii)	 training:	 specific	 competencies	 required	 for	 successful	 delivery	
of	 the	 intervention	 for	 training	 design;	 (iii)	 delivery:	 processes	 that	
monitor	and	maintain	quality	of	delivery;	 (iv)	 receipt:	processes	 that	
ensure	 that	participants	understand	 the	 information	provided	 in	 the	
intervention;	 and	 (v)	 enactment:	 processes	 to	monitor	 and	 improve	
the	ability	of	participants	to	perform	treatment-related	cognitive	and	
behavioural	strategies	in	their	daily	lives	[34,35].	
Measuring	 and	 assessing	 Treatment	 Fidelity	 provides	 a	 method	
to	 document	 deviations	 within	 and	 from	 an	 intended	 model	 and	
enhances	internal	and	external	validity,	and	reliability	of	behavioural	
research	interventions	[5,36-38].	Whilst	the	assessment	of	Treatment	
Fidelity	is	important,	it	can	also	be	resource-intensive	[39].	It	has	the	
potential to add an enhanced dimension to clinical trial implementation 
[40,41].	Perepletchokova	and	colleagues	[23]	emphasised	that	fidelity	
procedures	 and	 measures	 are	 central	 to	 the	 delivery	 of	 successful	
clinical	trials.	They	highlighted	four	key	areas	of	Treatment	Fidelity	in	
clinical	trials	that	included:	establishment	of	fidelity	(e.g.	specification	
of	protocol,	structured	training	of	therapists	and	continued	monitoring	
of	 therapist’s	 adherence	 to	 the	 prescribed	 procedures);	 assessment	
of	fidelity	 (e.g.	 assessed	via	direct	observations	 in	 areas	of	 treatment	
adherence,	 therapist	 competence	 and	 treatment	 differentiation),	
evaluation	 of	 fidelity	 (e.g.	 use	 of	 adherence	 and	 competence	 scales)	
and	reporting	of	fidelity	(e.g.	overall	integrity	of	treatment	the	extent	
to	 which	 all	 components	 were	 correctly	 implemented	 according	 to	
the	manual,	 and	component	 integrity-	 consistently	 implementing	all	
treatment	component	across	sessions).	This	measure	was	referred	to	as	
the	 Implementation	of	Treatment	 Integrity	Procedures	Scale	 (ITIPS)	
and	was	designed	to	evaluate	the	extent	clinical	trials	addressed	these	
four	defined	areas	[23].
Treatment fidelity and CONSORT
At	present	many	elements	of	Treatment	Fidelity	are	absent	from	the	
revised	CONSORT	statements	and	explanations	[42].	Persche	and	Page	
[25]	highlighted	that	though	the	CONSORT	Guidelines	are	regularly	
used	 in	 clinical	 trials,	 they	 are	 deficient	 in	 the	 area	 of	 supporting	
the	 attainment	 of	 high	 levels	 of	 Treatment	 Fidelity,	 potentially	
detracting	 from	 the	 effectiveness	 of	 the	 delivered	 intervention.	
Identified	deficiencies	of	the	CONSORT	Guidelines	include:	inability	
to	 capture	 the	 provision	 of	 clinician	 professional	 development	 and	
the	 inability	 to	 record	 the	 attainment	of	 clinically	 significant	 results.	
Moreover,	the	guidelines	are	ineffective	in	terms	of	assessing	treatment	
delivery,	 treatment	 receipt	 and	 treatment	 enactment	 [34,43].	 The	
identified	weaknesses	within	 the	present	CONSORT	guidelines	have	
direct	 implications	for	client	care,	as	 the	attainment	of	high	 levels	of	
Treatment	Fidelity	 is	often	critical	 for	program	goals	and	replication	
across	multiple	sites	[44].	
The	inclusion	of	Treatment	Fidelity	tools	can	assist	with	adequate	
testing	of	a	proposed	hypothesis,	and	can	enhance	statistical	power	for	
measures	of	 internal	validity,	From	the	point	of	view	of	translational	
research,	 it	 enhances	 the	 ability	 to	 replicate	 the	 treatment	 in	 other	
studies,	 promptly	 disseminate	 the	 treatment,	 and	 potentially	 to	
maximise	successful	patient/client	outcomes	[45,46].	In	contrast,	a	lack	
of	 attention	 to	Treatment	Fidelity	 implementation	may	 lead	 to	poor	
standardisation	within	and	across	treatments	in	clinical	trials	and	will	
contribute	to	an	inflated	error	variance,	decreased	statistical	power	and	
increased	likelihood	of	a	Type	II	Error	[47,48].	
Aim
This	 systematic	 review	 aims	 to	 identify	 how	 Treatment	 Fidelity	
has	been	implemented	in	clinical	trials	to	help	contribute	to	improved	
understanding	of	current	trends.	
The	 review	 appraises	 psychosocial	 clinical	 trials	 that	 specifically	
investigate	 Treatment	 Fidelity	 over	 the	 last	 decade.	 It	 uses	 the	
Implementation	of	Treatment	Integrity	Procedures	Scale	(ITIPS)	[23]	
to	critically	appraise	and	synthesize	evidence	in	terms	of:
1. Use	 of	 Treatment	 Fidelity	 procedures	 within	 clinical	 trials	 of
psychological	interventions
2. Alignment	of	 clinical	 trial	Treatment	Fidelity	procedures	with
the	Implementation	of	Treatment	Integrity	Procedures	Scale.
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Method
Types of studies
Only	randomised	control	trials	published	in	English	between	2004	
and	2014	were	included.	When	a	trial	did	not	report	randomisation	but	
was	described	as	“double-blind”	and	the	demographics	details	of	each	
group	were	similar,	the	trial	was	deemed	to	be	randomised.	The	authors	
excluded	quasi-randomised	studies,	but	studies	that	employed	“cluster	
randomisation”	(such	as	randomisation	by	clinician	or	practice)	were	
included.	
Search strategy
Prior	to	commencing	the	systematic	review,	a	preliminary	search	
of	 the	 Database	 of	 Abstracts	 of	 Reviews	 of	 Effects	 (DARE),	 and	
the	 Cochrane	 Database	 of	 Systematic	 Reviews	 (CDSR)	 confirmed	
no	 similar	 systematic	 reviews	 had	 been	 published.	 The	 following	
electronic	library	databases	were	investigated	by	two	research	assessors	
using	the	PRISMA	(2009)	Model	of	Systematic	Review:	The	Cochrane	
Central	 Register	 of	 Controlled	 Trials	 on	 the	 Cochrane	 Library	
(January	2004-January	2014);	PubMed	 (January	2004-January	2014);	
Ovid	 Medline	 (January	 2004-January	 2014);	 PsychINFO	 (January	
2004-January	 2014);	 CINAHL	 Plus	 (January	 2004-January	 2014);	
Scopus	(January	2004-January	2014).	Search	terms	included	treatment	
fidelity,	 integrity,	 intervention	 integrity,	 adherence,	 competence,	 and	
implement,	scale,	assessment,	and	monitor	and	outcome	measure.
Two	assessors	(Clinical	Psychologist	Ted	Graham	and	first	author-
PP)	independently	screened	titles	and	abstracts	based	on	the	research	
questions,	 study	 design,	 specified	 population,	 intervention,	 and	
outcome(s).	 Each	 individual	 article	was	 assessed	 using	 the	 inclusion	
criteria	of	randomised	control	trials,	mental	health	treatments,	English	
and	 full	 text	 articles.	The	exclusion	criteria	 consisted	of	poor	quality	
results,	 non-randomised	 control	 trial,	 not	 peer	 reviewed,	 meta-
analysis/systematic	 reviews,	 trials	 not	 explicitly	 assessing	 Treatment	
Fidelity,	 letters,	 opinions,	 inadequate	 considerations	 of	 confounders,	
development	 of	 scale	 articles,	 tools	 used	 not	 validated/reliable	 and	
qualitative	studies.	The	reference	lists	of	included	studies	and	reviews	
were	searched	to	help	identify	further	relevant	studies.	If	the	assessors	
agreed	 an	 assessed	 trial	 did	 not	 supply	 sufficient	 pre-requisite	 data,	
that	 study	 was	 omitted	 from	 the	 review.	 Publications	 were	 viewed	
individually	 and	 any	 double	 reporting	 recorded.	 Figure	 1	 shows	 the	
results	of	different	search	engines	[49].
Data extraction 
The	two	assessors	independently	extracted	data	from	the	selected	
32	articles	using	the	ITIPS.	To	maintain	data	integrity	this	information	
was	cross-checked	by	each	assessor.	In	the	event	consensus	could	not	
be	 reached	 pertaining	 to	 the	 rating	 of	 items	within	 the	 scale,	 Tricia	
Nagel	 (TN-second	 author)	 assisted	 in	making	 a	 final	 determination.	
Decisions	 requiring	 clarification	 or	 data	 extraction	 challenges	 were	
documented	for	future	discussion.
Measurement used for data management
The	 PRISMA	 (2009)	 Checklist	 for	 Systematic	 Review	 [31]	 is	 a	
structured	 way	 to	 summarise	 literature	 reviews,	 which	 was	 further	
complemented	by	 the	 inclusion	of	 the	Implementation	of	Treatment	
Procedures	Scale	(ITIPS).	The	ITIPS	was	designed	by	Perepletchikova	
and	colleagues	 [23]	 to	promote	a	common	 language	 to	best	position	
researchers	 to	understand,	measure	and	define	Treatment	Fidelity.	 It	
provides	a	 framework	to	systematically	evaluate	and	code	Treatment	
Fidelity	in	clinical	trials	[23,50].	The	ITIPS	consists	of	22-items	covering	
domains	 of	 establishment	 (use	 of	 treatment	 manuals),	 assessment	
(treatment	 adherence,	 therapist	 competence,	 evaluation	 (therapist	
reactivity	(e.g.	therapist	performance	altered	due	to	awareness	of	being	
observed)	and	reporting	(professional	development	of	 therapists	and	
raters	of	Treatment	Fidelity	in	outcomes	studies).	Each	of	the	22-items	
has	 a	 potential	 rating	 scale	 of	 four	 points.	 Total	 scores	 range	 from	
22	 to	 88.	 Higher	 scores	 indicate	 more	 adequate	 implementation	 of	
Treatment	Fidelity	procedures	(e.g.,	“Training	strategies	of	therapists,”	
where	1:	not	trained,	2:	authors	mentioned	that	therapists	were	trained	
but	no	other	information	was	provided,	3:	used	indirect	strategies,	and	
4:	used	direct	strategies).	The	establishing	treatment	fidelity	domain	(6	
items)	 refers	 to	how	researchers	 conceptualize	fidelity	 (e.g.,	 in	 terms	
of	adherence	and/or	competence),	as	well	as	the	extent	to	which	they	
provide	a	detailed	treatment	manual	to	therapists,	train	and	supervise	
them.	The	assessing	 treatment	fidelity	domain	(7	 items)	refers	 to	 the	
assessment	of	treatment	fidelity	via	direct,	indirect,	or	hybrid	strategies;	
measurement	of	therapist	treatment	adherence	as	well	as	competence;	
and	employment	of	fidelity	measures	with	good	psychometric	properties	
(i.e.,	 validity	 and	 reliability).	 The	 evaluating	 treatment	 integrity	
domain	(5	 items)	refers	 to	procedures	such	as	ensuring	the	accuracy	
of	 the	 representation	of	 the	obtained	fidelity	data,	 training	of	 raters,	
assessing	inter-rater	reliability,	and	controlling	for	measure	reactivity.	
The	reporting	treatment	fidelity	domain	(4	items)	refers	to	procedures	
such	 as	 reporting	 numerical	 data;	 reporting	 overall,	 component	 and	
session	fidelity;	 and	 reporting	 the	 implementation	of	 various	fidelity	
procedures.	Therapist	treatment	adherence	and	therapist	competence	
aspects	 of	 fidelity	 (6	 items	 each)	 encompass	 how	 the	 terms	 were	
defined,	assessed,	evaluated,	and	reported	[23].	To	reduce	the	risk	of	
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bias	associated	in	over-estimating	the	effects	assessors	rated	the	articles	
independently,	prior	 to	assigning	 ITIPS	 scores.	Assessor	 scores	were	
averaged	and	recorded	on	an	Excel	Spreadsheet	for	analysis.	
Treatment	 Fidelity	 procedures	 were	 categorised	 as	 determined	
by	the	ITIPS	guidelines:	adequate	(AD);	approaching	adequate	(AA);	
and	inadequate	(IA).	For	each	item	a	score	of	1	or	2	was	assumed	to	
reflect	 inadequate	 implementation	 of	 integrity	 procedures	 as	 the	
clinical	trial	showed	either	no	evidence	or	talked	only	in	broad	terms	
of	 Treatment	 Fidelity;	 a	 score	 of	 3	 indicated	 that	 implementation	
approached	adequacy	as	the	clinical	trial	had	provided	some	data	that	
measured	Treatment	Fidelity	 ;	 and	 a	 score	 of	 4	 designated	 adequate	
implementation	of	fidelity	procedures	as	the	clinical	trial	had	provided	
detailed	 data	 that	measured	 Treatment	 Fidelity.	 Because	 there	 were	
22	items	on	the	ITIPS,	studies	were	classified	as	implementing	fidelity	
procedures	(a)	inadequately	if	the	study’s	total	score	ranged	between	22	
and	44;	(b)	in	a	manner	approaching	adequacy	if	the	total	score	ranged	
between	45	and	66;	and	(c)	adequately	if	the	total	score	exceeded	66.	
This	 strategy	was	 also	 utilized	 for	 evaluation	 of	 the	 adequacy	 of	 the	
Treatment	Fidelity	procedures	for	the	four	domains	and	the	two	aspects	
of	fidelity.	Statistical	analysis	was	conducted	using	SPSS	for	Windows.	
Results
Figure	1	 illustrates	 the	flow	of	 information	 through	 the	different	
phases	of	the	systematic	review	and	maps	out	the	number	of	records	
identified,	included,	and	reasons	for	exclusions.	Thirty	two	studies	met	
all	selection	criteria	for	inclusion.	3224	records	were	excluded	due	to:	
non-RCT	design,	treatment	focus	not	psychosocial,	lack	of	appropriate	
fidelity	 measures	 or	 treatment	 fidelity	 definition,	 fewer	 than	 10	
participants,	and/or	lack	of	useable	data.
Establishing treatment fidelity
The	majority	of	studies	(71.9%)	reported	use	of	a	treatment	manual	
to	 support	 the	 therapist	as	 shown	 in	Table	1.	However,	more	 than	a	
quarter	(28.1%)	of	studies	made	no	reference	to	the	use	of	a	treatment	
manual.	Of	 the	 23	 studies	which	 used	 a	manual,	 14	 studies	 (43.5%)	
referred	to	the	use	of	a	specific	manual,	nine	studies	(28.1%)	mentioned	
the	general	use	of	a	manual	within	the	treatment	process.	
Assessment of adherence and competence procedures of the 
treatment
Table	1	also	shows	that	most	studies	(90.6%,	n=29)	approached	or	
achieved	adequacy	in	terms	of	use	of	treatment	adherence	procedures.	
Competence	 measures	 were	 less	 frequently	 employed.	 More	 than	
half	 of	 the	 studies	 (56.2%,	 n=18)	 approached	 or	 achieved	 adequacy	
of	 therapist	 implementing	 competence	 procedures	 while	 14	 studies	
(43.8%)	did	not	refer	to	the	use	of	therapist	competence	procedures.	
Evaluating treatment fidelity 
Clinician adherence and competence:	 Of	 the	 32	 studies	 that	
assessed	 Treatment	 Fidelity,	 most	 reported	 conceptualisation	 of	
Treatment	Fidelity	data.	Data	 included	competence	 raters,	 employed	
methodology	and	key	properties	of	the	treatment.	While	the	majority	
of	 these	 studies	 defined	 Treatment	 Fidelity	 specifically	 in	 terms	 of	
adherence	 and/or	 competence	 (59.4%,	 n=19),	 one	 third	 of	 studies	
appraised	Treatment	Fidelity	in	only	general	terms	(34%,	n=11),	(Table	
2).	 A	majority	 of	 studies	 (71.9%,	 n=23)	 assessed	 Treatment	 Fidelity	
using	adherence	and/or	competence	concepts,	and	half	of	the	studies	
(50%,	n=16)	used	specific	adherence	or	competence	tools	to	measure	
Treatment	Fidelity.
On	the	other	hand,	more	than	a	quarter	of	the	studies	(28%,	n=9)	
only	assessed	Treatment	Fidelity	indirectly	or	failed	to	provide	detail	of	
the	assessment	of	Treatment	Fidelity	(28.2%,	n=9).	Most	of	these	(six	
studies)	 referred	 to	Treatment	Fidelity	 indirectly	with	 the	 remaining	
three	studies	not	reporting	the	use	of	any	fidelity	tools.	Explaining	and	
assessing	(observational	data)	adherence	and	competence	can	involve	
direct,	 indirect	or	hybrid	strategies.	Direct	observations	are	generally	
conducted	 by	 trained	 staff	 present	 in	 the	 treatment	 setting,	 viewing	
sessions	 through	one-way	mirror	or	via	monitors	and/or	videotapes.	
Indirect	 methods	 include	 self-report,	 rating	 scales,	 interviews	 and	
permanent	 products	 (eg.	 written	 homework	 assignments	 or	 data	
collection	sheets)	of	treatment	implementation.		
Rating adherence and competence:	Evaluating	Treatment	Fidelity	
through	the	use	of	adherence	and	competence	scales	requires	the	use	
of	 raters	 who	 assess	 and	 score	 treatment	 delivered	 by	 clinicians	 or	
researchers.	Half	of	the	32	studies	(n=16)	did	not	report	any	training	
of	 raters,	 (Table	 3).	 In	 a	 third	 of	 the	 studies	 (31.3%,	 n=10)	 training	
provided	to	raters	was	indirect	or	not	specific	to	the	treatment.	Over	
two	 thirds	 of	 the	 studies	 (68.7%,	 n=22)	measured	 adherence	 and/or	
competence.	
A	 third	 of	 studies	 (31.3%,	 n=10)	 relied	 on	 indirect	measures	 to	
assess	 fidelity.	 Reactivity	 to	 Treatment	 Fidelity	 (clinicians	 altering	
their	 performance	 or	 behaviours	 due	 to	 the	 awareness	 that	 they	
are	 being	observed)	was	 controlled	within	 21	 studies	 (65.6%)	with	 a	
further	11	studies	(34.4%)	controlling	for	reactivity	indirectly.	That	is,	
observations	were	conducted	at	randomised	times	without	prior	notice	
being	provided	to	clinicians.
Reporting treatment fidelity:	Nine	 studies	provided	 informative	
data	related	to	therapist	adherence,	eight	of	which	provided	numerical	
data	related	to	measurement	of	Treatment	Fidelity	using	competence	
scales,	 (Table	4).	Of	 the	 remaining	23	 studies	using	adherence	 scales	
most	 (71.9%)	did	not	provide	detailed	 informative	data	of	 treatment	
adherence	 levels	 although	 they	 assessed	 treatment	 adherence	 and	
provided	numerical	data.	Of	the	24	which	did	not	provide	information	
Therapist treatment adherence procedures Therapist competence procedures Use of the manual
Variable
(ITIPS range)
IA
(6-12)
AA
(13-18)
AD
(19-24)
IA
(6-12)
AA
(13-18)
AD
(19-24)
Manual not 
mentioned
Manual only 
mentioned
Manual is 
general
Manual is 
specific
Overall (N) 3 17 12 14 9 9 9 14 4 5
Overall (%) 9.4% 53.1% 37.5% 43.8% 28.1% 28.1% 28.1% 43.8% 12.5% 15.6%
Mean Score 12 15.4 21 7.6 15.3 21.8
SD 0 1.8 1.7 1.5 1.9 1.9
Median 12 15.0 20.5 7 16 22
Min-Max 12-12 13-18 19-24 6-11 13-18 19-24
Table 1: Implementation of therapist treatment adherence and therapist competence procedures and use of the manual Note: IA=inadequate; AA=approaching adequacy; 
AD=adequate. Total studies N=32.
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about	competence	scales	12	studies	(37.5%)	provided	no	data	related	
to	competence	levels.	The	remaining	12	studies	(37.5%)	provided	some	
numerical	data,	however	it	was	not	sufficient	to	allow	determination	of	
competence	levels.	
Implementation of treatment fidelity procedures across the 
four domains of the ITIPS:	Table	5	shows	the	adequacy	levels	across	
the	four	domains	of	establishing,	assessing,	evaluating,	and	reporting	
fidelity.
I) Establishment:	 Less	 than	 half	 (40.6%,	 n=13)	 of	 the	 studies
established	procedures	for	ascertaining	Treatment	Fidelity	and	nearly	
a	 quarter	 (21.9,	 n=7)	 of	 the	 studies	 approached	 adequacy	 in	 this	
domain.	However,	more	than	one	third	of	studies	(37.5%,	n=12)	did	
not	establish	adequate	Treatment	Fidelity	procedures.	
II)	Assessment:	In	terms	of	assessing	Treatment	Fidelity	about	one
third	of	 studies	 (31.3%,	n=10)	 approached	adequacy,	 a	 further	 third	
of	studies	implemented	adequate	procedures	(34.4%,	n=11),	while	the	
remaining	third	of	studies	(34.3%,	n=11)	scored	within	the	inadequate	
range	on	the	ITIPS	scale.	
III) Evaluation:	Over	a	half	of	studies	(53.1%,	n=17)	approached
adequacy	in	terms	of	methods	of	evaluation	of	Treatment	Fidelity,	with	
markedly	 fewer	 (18.8%,	 n=6)	 achieving	 scores	 indicating	 adequate	
implementation.	 More	 than	 a	 quarter	 of	 the	 studies	 (28.1%,	 n=9)	
achieved	scores	which	indicated	inadequate	evaluation	procedures.
IV) Reporting:	 Approximately	 a	 third	 of	 studies	 approached
adequacy	 (31.3%,	n=10)	 in	 terms	of	 reporting	of	Treatment	Fidelity	
Establishing Assessing Evaluating Reporting
Variable
(ITIPS 
range)
IA
(6-12)
AA
(13-18)
AD
(19-24)
IA
(7-14)
AA
(15-20)
AD
(21-28)
IA
(5-10)
AA
(11-15)
AD
(16-20)
IA
(4-8)
AA
(9-12)
AD
(13-16)
Overall (N) 12 13 7 11 10 11 9 17 6 7 15 10
Overall (%) 37.5% 40.6% 21.9% 34.4% 31.3% 34.4% 28.1% 53.1% 18.8% 21.9% 46.9% 31.3%
Mean 
Score 10.8 15.2 21.0 12.1 16.7 24.1 8.9 12.9 17.5 7.3 10.7 14.5
SD 1.5 1.7 1.3 1.5 1.2 2.3 0.8 1.4 1.4 0.5 1.0 1.1
Median 11.5 15.0 22.0 12.0 16.5 24.0 9.0 13.0 17.5 7 11 14.5
Min-Max 8-12 13-18 19-22 10-14 15-19 21-28 8-10 11-15 16-19 7-8 9-12 13-16
Note: IA=inadequate; AA=approaching adequacy; AD=adequate. Total studies N=32. 
Table 5: Adequacy levels across the four domains of establishing, assessing, evaluating, and reporting fidelity.
No Indirect Adherence or competence
Adherence and 
competence No Indirect
Adherence or 
Competence Adherence and Competence
% 6.3 34.4 37.5 21.9 9.4 18.8 50.0 21.9
N 2 11 12 7 3 6 16 7
Table 2: Treatment Fidelity in terms of treatment adherence and therapist competence.
Training raters Assessment inter-rater reliability Control for measure reactivity
Yes No Indirect Yes (adherence or competence)
Yes(both adherence and 
competence No Indirect Yes No Indirect
% 18.7 50.0 31.3 53.1 15.6 0 31.3 65.6 0 34.4
N 6 16 10 17 5 0 10 21 0 11
 Table 3: Measuring Treatment Fidelity.
procedures	and	findings	with	even	more	(46.9%;	n=15)	demonstrating	
adequate	 reporting.	 However,	 seven	 studies	 (21.9%)	 did	 not	 report	
Treatment	Fidelity	procedures	adequately.	
Total levels of treatment fidelity implemented:	Overall	on	each	
of	 the	 22	 items,	 a	 score	of	 1	or	 2	was	 assumed	 to	 reflect	 inadequate	
implementation	 of	 integrity	 procedures;	 a	 score	 of	 3	 indicated	 that	
implementation	 approached	 adequacy;	 and	 a	 score	 of	 4	 reflected	
adequate	implementation	of	integrity	procedures.	The	overall	score	of	
each	clinical	trial	was	calculated	using	a	combination	of	the	percentage	
of	treatments	implementing	integrity	procedures	with	(a)	inadequately	
if	 the	 study’s	 total	 score	 ranged	between	22	and	44;	 (b)	 in	a	manner	
approaching	 adequacy	 if	 the	 total	 score	 ranged	 between	 45	 and	 66;	
and	 (c)	 adequately	 if	 the	 total	 score	 exceeded	 66.	The	 percentage	 of	
treatments	 implementing	 integrity	 procedures	 within	 each	 range	 of	
scores	was	calculated	and	shown	in	Table	6.	
Of	the	32	clinical	studies	within	this	systematic	review,	a	quarter	
of	 the	 studies	 (25%,	 n=8)	 did	 not	 adequately	 implement	 Treatment	
Fidelity.	 Three	 quarters	 of	 the	 reviewed	 studies	 either	 approached	
adequacy	(50%,	n=16)	or	were	adequate	(25%,	n=8)	in	implementing	
Treatment	Fidelity	procedures.	
Discussion
Whilst	solid	advances	 in	Treatment	Fidelity	research	continue	to	
be	made,	several	opportunities	to	strengthen	this	approach	are	yet	to	
be	 realised.	This	 review	 assessed	 32	 clinical	 trials	 of	which	only	fifty	
percent	adequately	addressed	Treatment	Fidelity.		
Adherence Competence
No Not informative Informative No Not informative Informative
% 0 71.9 28.1 37.5 37.5 25.0
N 0 23 9 12 12 8
Table 4:  Provision of numerical data of treatment adherence and competence in clinical trials.t
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Use of Treatment Fidelity Procedures within Clinical Trials 
of Psychological Interventions
This	review	found	gaps	across	all	four	domains	of	the	ITIPS	scale,	
with	12	 studies	 attaining	 inadequate	 scores	 for	 establishment,	 11	 for	
assessment,	nine	for	evaluation,	and	seven	for	reporting	of	Treatment	
Fidelity.	 Overall,	 a	 third	 of	 the	 selected	 articles	 showed	 inadequate	
implementation	of	Treatment	Fidelity.	In	some	cases,	the	poor	rating	
may	 reflect	 insufficient	 reporting	 rather	 than	 a	 lack	 of	 procedures,	
while	in	other	cases	the	establishment,	measurement,	or	evaluation	of	
Treatment	Fidelity	may	have	been	inadequate.	
Treatment	 Fidelity	 in	 psychosocial	 research	 is	 implemented	 in	
accordance	with	theoretical	and	procedural	models	of	adherence	and	
competence	measurements.	A	small	number	of	studies	addressed	both	
the	use	of	adherence	and	competence	measures	and	their	assessment.	
However,	more	 value	was	placed	on	 the	 assessment	of	 adherence	 to	
Treatment	 Fidelity	 than	 on	 therapist’s	 competence	 levels.	 Goense	
and	 colleagues	 [49]	 identified	 a	 similar	 trend	 in	 their	 review.	 The	
concept	of	adherence	within	Treatment	Fidelity	may	be	better	suited	to	
quantitative	measurement.	Adherence	measures	assess	how	frequently	
and	 to	 what	 degree	 the	 therapist	 ensures	 treatment	 “purity”	 [50].	
In	 contrast,	 it	 is	 difficult	 to	 provide	 a	 quantitative	 measurement	 of	
therapist	competence	in	implementing	the	treatment	without	relying	
heavily	upon	the	clinical	judgement	and	expertise	of	selected	assessors.	
Alignment of Clinical Trial Treatment Fidelity Procedures 
with the Implementation of Treatment Integrity Procedures 
Scale (ITIPS)
Across	 the	 four	 domains	 of	Treatment	 Fidelity	 in	 the	 ITIPS,	we	
found	that	methods	for	establishing	and	assessing	fidelity	scored	below	
fifty	percent	on	average,	whilst	the	evaluating	and	reporting	of	results	
approached	average	in	a	number	of	studies.	Only	seven	studies	(21.9%)	
had	 adequately	 established	 procedures	 for	 ascertaining	 Treatment	
Fidelity.	 Typically,	 a	 manual	 was	 provided	 for	 the	 therapist	 when	
implementing	 the	 treatment.	 However,	 it	 is	 noteworthy	 that	 only	
five	 studies	 reported	 providing	 therapists	 with	 a	 specific	 treatment	
manual.	Additionally,	not	all	studies	provided	therapists	with	training	
and/or	supervision	related	to	use	of	 the	manual	and	implementation	
of	 treatment.	 One	 explanation	 could	 be	 that	 the	 therapy	 was	 well	
known	and	that	guidelines	and	training	were	already	broadly	available.	
For	example,	several	studies	 involved	the	use	of	 the	widely	practiced	
treatment	of	Cognitive	Behavioural	Therapy.	
In	contrast,	it	would	be	expected	that	new	therapies	and	emerging	
interventions	would	place	greater	reliance	on	the	provision	of	a	specific	
manual.	It	should	be	noted	that	whilst	a	clinician	can	be	very	skilled	
in	 delivering	 a	 treatment,	 they	 may	 not	 necessarily	 be	 adhering	 to	
pertinent	techniques	contained	within	a	prescribed	manual.	In	terms	
of	assessment,	in	most	studies	indirect	methods	of	fidelity	assessment	
were	more	commonly	used	 than	 specific	adherence	and	competence	
scales.	A	key	limitation	of	such	indirect	methods	is	the	lack	of	capacity	
in	measuring	the	quality	of	the	delivered	intervention	or	treatment	[50].	
The	 fourth	and	final	domain,	 reporting,	 scored	poorly	overall.	 It	
appeared	 the	 reporting	 of	 Treatment	 Fidelity	 was	 influenced	 by	 the	
lack	 of	 establishment	 and	 implementation	 of	 rigorous	 assessment	
procedures	 across	 several	 studies.	 This	 rendered	 interpretation	
of	 fidelity	 data	 difficult.	 Clinician	 adherence	 was	 generally	 more	
adequately	reported	 than	clinician	competence	with	very	 few	studies	
reporting	both	adherence	and	competence	measures.	Numerous	studies	
were	deficient	in	reporting	critical	details	of	their	evaluation,	such	as	
inter-rater	 reliability.	 Moreover,	 when	 reporting	 Treatment	 Fidelity	
data,	many	studies	provided	little	detail	of	their	fidelity	measurement	
findings.	A	possible	explanation	may	be	authors	attached	more	weight	
to	 treatment	 outcomes	 than	 to	 the	 importance	 of	 assessing	 and	
reporting	 Treatment	 Fidelity.	 Nevertheless	 the	 failure	 to	 implement	
Treatment	 Fidelity	 strategies	 limits	 the	 available	 conclusions	 to	 be	
drawn	from	the	study	and	the	overall	generalizability	of	the	findings.
The	 findings	 of	 this	 systematic	 review	 suggested	 a	 need	 for	
guidelines	to	better	detail	the	key	Treatment	Fidelity	of	establishment,	
evaluation,	 assessment	 and	 reporting.	 	 The	 clinical	 trials	 in	 this	
review	 had	 implemented	 and	 reported	 according	 to	 the	 CONSORT	
Guidelines	[31];	however,	the	quality	of	fidelity	processes	was	generally	
inadequate	 with	 a	 majority	 of	 studies	 insufficiently	 reporting	 both	
therapist	 adherence	 and	 competence	 measurements.	 Whilst	 it	 is	
recognised	 that	 conceptualising	and	evaluating	Treatment	Fidelity	 is	
critical	in	understanding	the	validity	of	research	results,	clinical	trials	
can	still	achieve	this	 ‘gold	standard’	without	evidence	of	high	quality	
Treatment	 Fidelity	 procedures.	 Perrepletchikova	 and	 colleagues	 [23]	
argued	 that	 Treatment	 Fidelity	 needs	 to	 be	 elevated	 in	 prominence	
and	 to	be	viewed	as	 fundamental	 for	empirical	 research.	Our	 review	
supports	 this	 argument.	 This	 review	 highlights	 an	 opportunity	 for	
strengthened	 program	 implementation	 through	 adopting	 enhanced	
procedures	 for	 future	 clinical	 trials	 to	 maximise	 outcomes,	 a	 view	
shared	 by	 Perepletchivova	 and	 colleagues	 [23]	 who	 stated	 that,	
“guidelines	of	empirical	testing	of	psychological	treatment	require	re-
evaluation”	 (p838).	This	review	provides	 further	evidence	 in	support	
of	this	recommendation.	Moreover,	changes	are	recommended	to	the	
Guidelines	for	reporting	of	clinical	trials	for	psychological	research	to	
better	communicate	procedures	for	establishing	assessing,	evaluating,	
and	reporting	of	fidelity.	A	review	of	 the	CONSORT	guidelines	 [32]	
would	provide	an	opportunity	for	amendments	to	establish	procedures	
for	 ascertaining	 Treatment	 Fidelity	 across	 each	 of	 the	 four	 ITIPS	
domains.	Whilst	 the	guidelines	provide	a	 solid	 starting	point	 for	 the	
reporting	 of	 clinical	 trials,	 they	 remain	 vague	 in	 terms	 of	 reporting	
on	 Treatment	 Fidelity.	 Borrelli	 and	 colleagues	 [34]	 suggested	 the	
addition	 of	 a	 fidelity	 framework	 to	 best	 support	 treatment	 design,	
therapist	training,	treatment	delivery,	treatment	receipt	and	treatment	
enactment.	
The	 benefits	 of	 revising	 the	 CONSORT	 Guidelines	 include:	
establishing	 a	 structured	 Treatment	 Fidelity	 focus,	 increased	 usage	
of	 treatment	 manuals,	 enhanced	 consistency	 of	 clinician	 treatment	
implementation,	 and	 greater	 statistical	 power	 achieved	 through	 a	
more	standardised	measurement	method.	This	review	suggests	the	best	
suited	tools	to	deliver	high	levels	of	Treatment	Fidelity	were	adherence	
scales,	competence	scales	and	specific	manuals.	These	tools	provide	a	
constant	reference	point	to	better	support	consistency	in	the	delivery	
of	a	program	across	multiple	sites	by	different	clinicians.
Note: IA=inadequate; AA=approaching adequacy; AD=adequate. Total studies 
N=32.
Table 6: Adequacy levels of the total implementation of Treatment Fidelity 
procedures in 32 clinical trials studies.t.
Total Treatment Fidelity
Variable (ITIPS range) IA (22-44) AA (45-66) AD (67-88)
Overall (N) 8 16 8
Overall (%) 25 50 25
Mean score 38.75 54.81 76.75
SD 2.49 5.59 4.83
Median 38.50 54.00 73.50
Min-Max 35-42 47-64 70-83
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The	 ITIPS	 domains	 of	 establishment,	 evaluating,	 assessing,	 and	
reporting	 Treatment	 Fidelity	 supported	 the	 goals	 of	 this	 systematic	
review.	 However,	 some	 minor	 refinement	 may	 prove	 beneficial	 for	
future	 research	 studies.	 The	 intentional	 broadness	 of	 the	 domains	
makes	it	difficult	to	effectively	drill	down	to	specific	elements	of	interest.	
For	example,	it	is	not	possible	to	readily	capture	the	specific	Treatment	
Fidelity	tools	used	or	professional	development	opportunities	provided	
to	clinicians.	Accordingly,	 the	option	to	 include	additional	questions	
within	domains	may	help	overcome	this	identified	limitation.
Limitations
There	are	five	main	limitations	to	this	study.	Firstly,	the	assessors	
were	 not	 blind	 to	 the	 authors	 of	 the	 selected	 clinical	 trials	 allowing	
for	 the	 potential	 of	 observer	 bias.	 Secondly,	 inclusion	 and	 exclusion	
criteria	may	have	been	too	restrictive	with	specific	search	terms	having	
unintentionally	excluded	valid	clinical	trials.	Thirdly,	the	small	number	
of	clinical	trials	included	affects	the	generalisability	of	the	current	study.	
Perhaps	having	a	 longer	 time	 frame	and	 including	studies	published	
prior	to	2004	may	have	led	to	a	better	understanding	of	the	evolving	
nature	of	Treatment	Fidelity.	
Fourthly,	expanding	 the	review	parameters	 from	clinical	 trials	 to	
include	 systematic	 reviews	 and	 meta-analyses	 may	 have	 provided	 a	
more	heterogeneous	field	for	comparison.	Finally,	Treatment	Fidelity	
was	identified	as	not	commonly	being	the	specific	focus	of	the	clinical	
trials,	 and	 these	 studies	 were	 often	 undertaken	 by	 a	 core	 group	 of	
authors.	 For	 example,	Hogue	 contributed	 to	 three	 separate	 included	
trials.	 This	 makes	 it	 problematic	 to	 generalise	 findings	 given	 the	
potential	for	bias	linked	with	this	research	group.	
Conclusion and future directions
Mental	health	professionals	working	within	the	fields	of	psychology	
and	psychiatry	seek	evidence-based	treatments	to	underpin	their	day	
to	 day	 clinical	work.	High	 quality	Treatment	 Fidelity	within	 clinical	
trials	 provides	 robust	 evidence	 for	 effectiveness	 of	 a	 given	 therapy.	
This	 systematic	 review,	 however,	 found	 under-usage	 of	 fidelity	
measures	 within	 clinical	 trials,	 contributing	 to	 limited	 quality	 of	
Treatment	Fidelity,	and	consequent	limited	evidence	for	effectiveness	
of	 therapy.	The	review	also	 found	 that	 those	studies,	which	 included	
multi-method	 approaches	 to	 Treatment	 Fidelity	 using	 adherence	
and	 competence	 measures	 and	 treatment	 manuals,	 achieved	 higher	
ratings	 of	 Treatment	 Fidelity	 quality.	 This	 provides	 clear	 direction	
for	 future	research,	suggesting	that	 inclusion	of	such	procedures	will	
promote	improved	Treatment	Fidelity.	While	the	development	of	the	
CONSORT	Guidelines	has	contributed	to	improved	quality	of	clinical	
trials	and	hence	strengthened	the	evidence	base	for	specific	therapies,	
these	 protocols	 do	 not	 presently	 provide	 detailed	 recommendations	
related	to	Treatment	Fidelity	procedures.	Thus	one	means	of	improving	
quality	of	Treatment	Fidelity	in	clinical	trials	would	be	the	inclusion	of	
such	detailed	guidance.	
This	review	evaluated	Treatment	Fidelity	quality	in	four	procedural	
domains;	 establishment,	 evaluation,	 assessment,	 and	 reporting.	
Integrating	 procedures	within	 these	 domains	 in	 future	 clinical	 trials	
will	provide	data,	which	promotes	greater	understanding	of	treatment	
implementation	and	strengthened	evidence	for	treatment	effectiveness.	
Reaching	 agreement	 on	 core	measures	 and	 fidelity	 tools	 to	 support	
improved	 levels	 of	 Treatment	 Fidelity	 in	 psychosocial	 research	 will	
promote	quality	of	Treatment	Fidelity,	and	consistency	across	mental	
health	 disciplines,	 allowing	 future	 research	 to	 provide	 more	 robust	
evidence	in	support	of	better	client	outcomes.	
Acknowledgment
This project would have not been possible without the assistance of Ted 
Graham (Clinical Psychologist and Research Assistant) and Anne Young 
(Librarian, Monash University Melbourne).
References
1. Leichsenring F, Salzer SJ, Hilsenroth M, Leibing E (2011) Treatment integrity:
An unresolved issue in psychotherapy research. Current Psychiatry Reviews
7: 313-321.
2. Kazdin AE (1986) Comparative outcome studies of psychotherapy:
Methodological issues and strategies. J Consult Clin Psychol 54: 95-105.
3. Yeaton WH, Sechrest L (1981) Critical dimensions in the choice and
maintenance of successful treatments: Strength, integrity, and effectiveness. J
Consult Clin Psychol 49: 156-167.
4. Moncher FJ, Prinz FJ (1991) Treatment fidelity in outcome studies. Clinical 
Psychology Review 11: 247-266.
5. Riedel BW, Lichstein KL (1994) Behavioral assessment and treatment of
insomnia: a review with an emphasis on clinical application. Behavior Therapy
25: 659-688.
6. Burgio L, Corcoran M, Lichstein K, Nichols L, Czaja S, et al. (2001) Judging
outcomes in psychosocial interventions for dementia caregivers: The problem
of treatment implementation. The Gerontologist 4: 481-489.
7. Lichstein KL, Riedel BW, Grieve R (1994) Fair tests of clinical trials: A treatment 
implementation model. Advances in Behavior Research and Therapy 16: 1-29.
8. Wilson GT (1996) Manual-based treatments: The clinical application of research 
findings. Behaviour Research and Therapy 34: 295-314.
9. Town JM, Diener MJ, Abbass A, Leichsenring F, Driessen E, et al. (2012) A
meta-analysis of psychodynamic psychotherapy outcomes: Evaluating the
effects of research-specific procedures. Psychotherapy 49: 276.
10. Chorpita BF, Taylor AA, Francis SE, Moffitt C, Austin AA (2004) Efficacy of 
modular cognitive behavior therapy for childhood anxiety disorders. Behavior
Therapy 35: 263-287.
11. Lopata C, Thomeer ML, Volker MA, Nida RE, Lee GK (2008) Effectiveness of a 
manualized summer social treatment program for high-functioning children with 
autism spectrum disorders. J Autism Dev Disord 38: 890-904.
12. Moretti MM, Obsuth I (2009) Effectiveness of an attachment-focused
manualized intervention for parents of teens at risk for aggressive behaviour:
The Connect Program. Journal of Adolescence 32: 1347-1357.
13. Smith SW, Daunic AP, Taylor GG (2007) Treatment fidelity in applied educational 
research: Expanding the adoption and application of measures to ensure
evidence-based practice. Education and Treatment of Children 30: 121-134.
14. Binder JL (1993) Is it time to improve psychotherapy training? Clinical
Psychology Review 13: 301-318.
15. Binder JL (1999) Issues in teaching and learning time-limited psychodynamic
psychotherapy. Clin Psychol Rev 19: 705-719.
16. Strupp HH, Anderson T (1997) On the limitations of therapy manuals. Clinical
Psychology Science and Practice 4: 76-82.
17. Hilsenroth MJ, Defife JA, Blagys MD, Ackerman SJ (2006) Effects of training 
in short-term psychodynamic psychotherapy: Changes in graduate clinician
technique. Psychotherapy Research 16: 293-305.
18. Strupp HH, Anderson T (1997) On the limitations of therapy manuals. Clinical
Psychology, Science & Practice 4: 76-82.
19. Hogue A, Henderson CE, Dauber S, Barajas PC, Fried A, et al. (2008)
Treatment adherence, competence, and outcome in individual and family
therapy for adolescent behavior problems. J Consult Clin Psychol 76: 544.
20. Waltz J, Addis ME, Koerner K, Jacobson NS (1993) Testing the integrity of a
psychotherapy protocol: assessment of adherence and competence. Journal of 
consulting and clinical psychology 61: 620.
Citation:Prowse PTD, Nagel T, Meadows GN, Enticott JC (2015) Treatment Fidelity Over the Last Decade in Psychosocial Clinical Trials Outcome 
Studies: A Systematic Review. J Psychiatry 18: 258. doi:10.4172/Psychiatry.1000258
Volume 18 • Issue 2 • 1000258
J Psychiatry 
Psychiatry, an open access journal
Page 8 of 8
21. Webb CA, DeRubeis RJ, Barber JP (2010) Therapist adherence/competence
and treatment outcome: A meta-analytic review. Journal of Consulting and
Clinical Psychology 78: 200.
22. Fixsen DL, Naoom SF, Blase KA, Friedman RM, Wallace F (2005)
Implementation research: A synthesis of the literature. Tampa, FL: University
of South Florida, Louis de la Parte Florida Mental Health Institute, The National 
Implementation Research Network (FMHI Publication #231).
23. Perepletchikova F, Treat TA, Kazdin AE (2007) Treatment integrity in
psychotherapy research: analysis of the studies and examination of the
associated factors. J Consul Clin Psychol 75: 829.
24. Carpenter JS, Burns DS, Wu J, Yu M, Ryker K, et al. (2013) Strategies used
and data obtained during treatment fidelity monitoring. Nurs Res 62: 59.
25. Persch AC, Page SJ (2013) Protocol development, treatment fidelity, adherence 
to treatment, and quality control. Am J Occup Ther 67: 146-153.
26. Resnick B, Galik E, Enders H, Sobol K, Hammersla M, et al. (2011) Pilot testing 
of function-focused care for acute care intervention. J Nur Care Qual 26: 169-177.
27. Robb SL, Burns DS, Docherty SL, Haase JE (2011) Ensuring treatment fidelity 
in a multi‐site behavioral intervention study: implementing NIH behavior change 
consortium recommendations in the SMART trial. Psycho‐Oncology 20:
1193-1201.
28. Garbacz L, Brown D, Spee G, Polo A, Budd K (2014) Clinical Child and Family 
Psychology Review 17: 230-247.
29. Perepletchikova F, Kazdin AE (2005) Treatment integrity and therapeutic
change: Issues and research recommendations. Clinical Psychology: Science
and Practice 12: 365-383.
30. Dickersin K, Chan SS, Chalmersx TC, Sacks HS, Smith H (1987) Publication
bias and clinical trials. Control clin trials 8: 343-353.
31. Moher D, Liberati A, Tetzlaff J, Altman D (2009) The PRISMA Group-Preferred
Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA
Statement. 
32. Mohera D, Hopewellb S, Schulzc KF,  Montorid V, Gøtzschee PC, et al. (2010) 
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting 
parallel group randomised trials. Journal of Clinical Epidemiology: 63
33. Rennie D (1996) How to report randomized controlled trials: the CONSORT
statement. JAMA 276: 649-649.
34. Borrelli B, Sepinwall D, Belllg AJ, Breger R, DeFrancesco C, et al. (2005) A New 
Tool to Assess Treatment Fidelity and Evaluation of Treatment Fidelity Across
10 Years of Health Behaviour Research. J  Consult Clin Psychol 73: 852-860.
35. Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, et al. (2004) Enhancing
treatment fidelity in health behaviour change studies: best practices and 
recommendations from the NIH Behavior Change Consortium. Health Psychol
23: 443-451.
36. Bond GR, Becker DR, Drake RE (2011) Measurement of Fidelity of
Implementation of Evidence‐Based Practices: Case Example of the IPS Fidelity 
Scale. Clinical Psychology: Science and Practice 18: 126-141.
37. Carroll C, Patterson M, Wood S, Booth A, Rick J, et al. (2007) A conceptual
framework for implementation fidelity. Implementation Science 2: 1-9.
38. Mowbray CT, Holter MC, Teague GB, Bybee D (2003) Fidelity criteria:
Development, measurement, and validation. American Journal of Evaluation
24: 315-340.
39. Stein KF, Sargent JT, Rafaels N (2007) Intervention research: establishing
fidelity of the independent variable in nursing clinical trials. Nurs Res 56: 54-62.
40. MacPherson H, Altman DG, Hammerschlag R, Youping L (2010) Revised
standards for reporting interventions in clinical trials of acupuncture (STRICTA): 
extending the CONSORT statement. Journal of Evidence‐Based Medicine 3:
140-155.
41. Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated
guidelines for reporting parallel group randomised trials. BMC Medicine 8: 18.
42. Gutman, Murphy (2012).
43. Davidson KW, Goldstein M, Kaplan RM, Kaufmann PG, Knatterud GL, et al.
(2003) Evidence-based behavioral medicine: what is it and how do we achieve 
it? Ann Behav Med 26: 161-171.
44. Sloan JA, Cella D, Frost M, Guyatt GH, Sprangers M, et al. (2002) Assessing 
clinical significance in measuring oncology patient quality of life: Introduction 
to the symposium, content overview and definition of terms. Mayo Clin Proc 
77: 367-370.
45. Godwin M, Ruhland L, Casson I, MacDonald S, Delva, D, et al. (2003) Pragmatic 
controlled clinical trials in primary care: the struggle between external and
internal validity. BMC Med Res Methodol 3: 28.
46. Mark MM (1983) Treatment implementation, statistical power, and internal
validity. Evaluation Review 7: 543-549.
47. Stone-Romero EF, Alliger GM, Aguinis H (1994) Type II error problems in the
use of moderated multiple regression for the detection of moderating effects of 
dichotomous variables. Journal of Management 20: 167-178.
48. Litière S, Alonso A, Molenberghs G (2007) Type I and Type II Error Under
Random‐Effects Misspecification in Generalized Linear Mixed Models. 
Biometrics 63: 1038-1044.
49. Goense P, Boendermaker L, van Yperen T, Stams G J, van Laar J (2014)
Implementation of treatment integrity procedures: An analysis of outcome
studies of youth interventions targeting externalizing behavioral problems.
Zeitschrift für Psychologie 222: 12.
50. Weck F, Weigel M, Richtberg S, Stangier U (2011) Reliability of adherence and 
competence assessment in psychoeducational treatment influence of clinical 
experience. J Nerv Ment Dis 199: 983-986.
Submit your next manuscript and get advantages of OMICS 
Group submissions
Unique features:
•	 User	friendly/feasible	website-translation	of	your	paper	to	50	world’s	leading	languages
•	 Audio	Version	of	published	paper
•	 Digital	articles	to	share	and	explore
Special features:
•	 400	Open	Access	Journals
•	 30,000	editorial	team
•	 21	days	rapid	review	process
•	 Quality	and	quick	editorial,	review	and	publication	processing
•	 Indexing	at	PubMed	(partial),	Scopus,	EBSCO,	Index	Copernicus	and	Google	Scholar	etc
•	 Sharing	Option:	Social	Networking	Enabled
•	 Authors,	Reviewers	and	Editors	rewarded	with	online	Scientific	Credits
•	 Better	discount	for	your	subsequent	articles
Submit	your	manuscript	at:	http://www.editorialmanager.com/jmgm/
Citation: Prowse PTD, Nagel T, Meadows GN, Enticott JC (2015) Treatment 
Fidelity Over the Last Decade in Psychosocial Clinical Trials Outcome Studies: 
A Systematic Review J Psychiatry 18: 258. doi:10.4172/Psychiatry.1000258
